Michael Riediker1, Leonardo Briceno-Ayala2, Gaku Ichihara3, Daniele Albani4, Deyan Poffet5, Dai-Hua Tsai1, Samuel Iff6, Christian Monn6. 1. Swiss Centre for Occupational and Environmental Health, Winterthur, Switzerland. 2. Universidad del Rosario, Escuela de Medicina y Ciencias de la Salud, Bogota, Colombia. 3. Tokyo University of Science, Faculty of Pharmaceutical Sciences, Health Management Center, Chiba, Japan. 4. Repubblica e Cantone Ticino, Dipartimento del territorio, Camorino, Switzerland. 5. Centre for Primary Care and Public Health (Unisanté), Department of Occupational and Environmental Health, Lausanne, Switzerland. 6. State Secretariat for Economic Affairs (SECO), Working Conditions Section, Bern, Switzerland.
Abstract
BACKGROUND: Airborne transmission of SARS-CoV-2 is an important route of infection. For the wildtype (WT) only a small proportion of those infected emitted large quantities of the virus. The currently prevalent variants of concern, Delta (B1.617.2) and Omicron (B.1.1.529), are characterized by higher viral loads and a lower minimal infective dose compared to the WT. We aimed to describe the resulting distribution of airborne viral emissions and to reassess the risk estimates for public settings given the higher viral load and infectivity. METHOD: We reran the Monte Carlo modelling to estimate viral emissions in the fine aerosol size range using available viral load data. We also updated our tool to simulate indoor airborne transmission of SARS-CoV-2 by including a CO2 calculator and recirculating air cleaning devices. We also assessed the consequences of the lower critical dose on the infection risk in public settings with different protection strategies. RESULTS: Our modelling suggests that a much larger proportion of individuals infected with the new variants are high, very high or super-emitters of airborne viruses: for the WT, one in 1,000 infected was a super-emitter; for Delta one in 30; and for Omicron one in 20 or one in 10, depending on the viral load estimate used. Testing of the effectiveness of protective strategies in view of the lower critical dose suggests that surgical masks are no longer sufficient in most public settings, while correctly fitted FFP2 respirators still provide sufficient protection, except in high aerosol producing situations such as singing or shouting. DISCUSSION: From an aerosol transmission perspective, the shift towards a larger proportion of very high emitting individuals, together with the strongly reduced critical dose, seem to be two important drivers of the aerosol risk, and are likely contributing to the observed rapid spread of the Delta and Omicron variants of concern. Reducing contacts, always wearing well-fitted FFP2 respirators when indoors, using ventilation and other methods to reduce airborne virus concentrations, and avoiding situations with loud voices seem critical to limiting these latest waves of the COVID-19 pandemic.
BACKGROUND: Airborne transmission of SARS-CoV-2 is an important route of infection. For the wildtype (WT) only a small proportion of those infected emitted large quantities of the virus. The currently prevalent variants of concern, Delta (B1.617.2) and Omicron (B.1.1.529), are characterized by higher viral loads and a lower minimal infective dose compared to the WT. We aimed to describe the resulting distribution of airborne viral emissions and to reassess the risk estimates for public settings given the higher viral load and infectivity. METHOD: We reran the Monte Carlo modelling to estimate viral emissions in the fine aerosol size range using available viral load data. We also updated our tool to simulate indoor airborne transmission of SARS-CoV-2 by including a CO2 calculator and recirculating air cleaning devices. We also assessed the consequences of the lower critical dose on the infection risk in public settings with different protection strategies. RESULTS: Our modelling suggests that a much larger proportion of individuals infected with the new variants are high, very high or super-emitters of airborne viruses: for the WT, one in 1,000 infected was a super-emitter; for Delta one in 30; and for Omicron one in 20 or one in 10, depending on the viral load estimate used. Testing of the effectiveness of protective strategies in view of the lower critical dose suggests that surgical masks are no longer sufficient in most public settings, while correctly fitted FFP2 respirators still provide sufficient protection, except in high aerosol producing situations such as singing or shouting. DISCUSSION: From an aerosol transmission perspective, the shift towards a larger proportion of very high emitting individuals, together with the strongly reduced critical dose, seem to be two important drivers of the aerosol risk, and are likely contributing to the observed rapid spread of the Delta and Omicron variants of concern. Reducing contacts, always wearing well-fitted FFP2 respirators when indoors, using ventilation and other methods to reduce airborne virus concentrations, and avoiding situations with loud voices seem critical to limiting these latest waves of the COVID-19 pandemic.
Authors: Carlos Eduardo Covantes-Rosales; Victor Wagner Barajas-Carrillo; Daniel Alberto Girón-Pérez; Gladys Alejandra Toledo-Ibarra; Karina Janice Guadalupe Díaz-Reséndiz; Migdalia Sarahy Navidad-Murrieta; Guadalupe Herminia Ventura-Ramón; Mirtha Elena Pulido-Muñoz; Ulises Mercado-Salgado; Ansonny Jhovanny Ojeda-Durán; Aimée Argüero-Fonseca; Manuel Iván Girón-Pérez Journal: Int J Environ Res Public Health Date: 2022-05-08 Impact factor: 4.614
Authors: Lara Moeller; Florian Wallburg; Felix Kaule; Stephan Schoenfelder Journal: Int J Environ Res Public Health Date: 2022-05-22 Impact factor: 4.614
Authors: Arjan van Laarhoven; Marien I de Jonge; Lisa Kurver; Corné H van den Kieboom; Kjerstin Lanke; Dimitri A Diavatopoulos; Gijs J Overheul; Mihai G Netea; Jaap Ten Oever; Reinout van Crevel; Karin Mulders-Manders; Frank L van de Veerdonk; Heiman Wertheim; Jeroen Schouten; Janette Rahamat-Langendoen; Ronald P van Rij; Teun Bousema Journal: Sci Rep Date: 2022-05-30 Impact factor: 4.996
Authors: Kurt J Vandegrift; Michele Yon; Meera Surendran-Nair; Abhinay Gontu; Saranya Amirthalingam; Ruth H Nissly; Nicole Levine; Tod Stuber; Anthony J DeNicola; Jason R Boulanger; Nathan Kotschwar; Sarah Grimké Aucoin; Richard Simon; Katrina Toal; Randall J Olsen; James J Davis; Dashzeveg Bold; Natasha N Gaudreault; Juergen A Richt; James M Musser; Peter J Hudson; Vivek Kapur; Suresh V Kuchipudi Journal: bioRxiv Date: 2022-02-07
Authors: Evropi Amanatidou; Anna Gkiouliava; Eva Pella; Maria Serafidi; Dimitrios Tsilingiris; Natalia G Vallianou; Irene Karampela; Maria Dalamaga Journal: Metabol Open Date: 2022-03-17